Overview of the CONFORM™ Platform The CONFORM™ platform by EDETEK offers a multifaceted approach to managing clinical data, focusing on…
Browsing: General
Presented by Dr. Hedyeh Ebrahimi, City of Hope Overview: At the ASCO 2024 conference, Dr. Hedyeh Ebrahimi of City of…
Introduction During the CAR-T & Bispecifics Conference, Dr. Brian Sworder, MD, from UCI Irvine, shared compelling insights on the utility…
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set a benchmark in oncology, providing…
Preventing a Carboplatin Shortage: Strategies to Ensure Cancer Drug Availability in 2023 In an era where advancements in cancer treatment…
In a discussion with Allen Wilbanks from Oncology Tube, Brandon McNaughton, CEO & Founder of Akadeum Life Sciences, shed light…
OneOncology, a rapidly expanding national platform for independent medical practices, proudly announces the completion of 25 distinctive oncology and hematology…
The interview with Jill O’Donnell-Tormey, PhD, delves into the vital topic of cancer immunotherapy and research, emphasizing the transformative potential…
Joshua Brody, MD – Director, Lymphoma Immunotherapy Program Icahn School of Medicine at Mount SinaiHess Center for Science and Medicine…
Presented By: Brian Warnecke, DO – UC-Irvine Hematology Oncology Fellow, PGY-5 Date: August 12, 2023The presentation titled “Multi-omic Characterization of…
Clinical trials, as many are aware, often face numerous failures. Countless molecules are tested before finding a successful one. Anju,…
The Impact of ASCO 2022 on Oncology In the ever-evolving field of oncology, ASCO 2022 stands out as a landmark…
Laure-Anne Teuwen, MD, PhD from Antwerp University Hospital, and Joanna Young, DO, FACP from Blue Ridge Cancer Care examined the…
ASCO 2023 Press Briefing June 6, 2024 with Julie Gralow, MD ASCO Chief Medical Officer
For this year’s Targeted Therapies Forum, Dr. Narjust Florez, Associate Director, Cancer Care Equity Program, Dana-Farber Cancer Institute; Assistant Professor…
For this year’s Targeted Therapies Forum, Dr. Narjust Florez, Associate Director, Cancer Care Equity Program, Dana-Farber Cancer Institute; Assistant Professor…
For this year’s Targeted Therapies Forum, Dr. Narjust Florez, Associate Director, Cancer Care Equity Program, Dana-Farber Cancer Institute; Assistant Professor…
For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…
For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…
El Dr. Eric Singh, uno de los participantes en el Programa de Embajadores de Educación para Pacientes GRACE del año…
Dr. Eric Singh, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video…
John Strickler, MD, Associate Professor of Medicine, Member of the Duke Cancer Institute at Duke University. In this video, he…
John Strickler, MD, Associate Professor of Medicine, Member of the Duke Cancer Institute at Duke University. In this video, he…
Dr. Jeffrey Zonder, MD is a Hematology Specialist in Detroit, Michigan, with over 26 years of expertise. In 1995, he…
Dr. Shikha Jain of the University of Illinois & Chair of the Women in Medicine Summit joins Charu Aggarwal &…
Professor Yves Chabu, Ph.D. from MU College of Arts and Science speaks about Understanding How Cancer Can Relapse.Link to Abstract:https://showme.missouri.edu/2021/understanding-how-cancer-can-relapse/Activating…
David Illson, MD, Ph.D., Memorial Sloan Kettering Cancer Center and a professor of medicine at Weill Cornell Medical College.@ILSONDavid @sloan_kettering…
Dr. Matthew Katz, radiation oncologist in Lowell, MA, speaks with Drs. Jack West & Charu Aggarwal about the evolution of…
Dr. Larry Shulman of University of Pennsylvania meets with hosts Charu Aggarwal & Jack West to discuss the promise &…
Hosts Jack West and Charu Aggarwal meet with Dr. Vince Miller to discuss the process of deciding to move from…
David Illson, MD, Ph.D., Memorial Sloan Kettering Cancer Center and a professor of medicine at Weill Cornell Medical College.@ILSONDavid @sloan_kettering…
Professor Yves Chabu, Ph.D. from MU College of Arts and Science speaks about Understanding How Cancer Can Relapse.Link to Abstract:https://showme.missouri.edu/2021/understanding-how-cancer-can-relapse/Activating…
Dr. Steve Vogl of “Vogl, New York” fame joins hosts Charu Aggarwal and Jack West as they discuss the priorities…
Drs. Aggarwal & West welcome Drs. Jerad Gardner from Geisenger Medical Labs & Sanjay Mukhopadyay from Cleveland Clinic as they…
Johannes A. Schmid, Ph.D. from MedUni Vienna speaks about How inflammatory signaling molecules contribute to carcinogenesis.Link to Article -https://www.sciencedaily.com/releases/2021/02/210217114327.htmThe Whole…
Co-hosts Charu Aggarwal and Jack West are joined by Dr. Toni Choueiri to discuss the role of twitter for education,…
Co-hosts Charu Aggarwal and Jack West are joined by Dr. Don Dizon to discuss the role social media plays in…
Drs. West and Aggarwal host Dr. Nora Disis of Univ of Washington, Editor-in-Chief of JAMA Oncology as they discuss how…
Martin Dietrich, MD from Florida Cancer Specialists speaks about the FDA Approves FoundationOne®CDx as Companion Diagnostic for Vitrakvi® (larotrectinib), to…
Co-hosts Charu Aggarwal and Jack West are joined by Dr. Jamie Von Roenn and Christopher Merlan to discuss the landscape…
In this edition of The Onco’Zine Brief Peter Hofland talks with Peter Keeling about Personalized Medicine, diagnostic testing, and the…
In this episode of The Onco’Zine Brief Peter Hofland Ph.D., talks with Raj Malik M.D. and Robert Epstein M.D.Malik is…
Pablo Okhuysen, MD, FACP, FIDSA of MD Anderson discusses the Jaguar Health Subsidiary Napo Pharmaceuticals Initiates Pivotal Phase 3 Clinical…
Drs. Charu Aggarwal and Jack West chat with Dr. Gil Morgan, Medical Oncologist at SkÃ¥ne University Hospital in Lund, Sweden…
Filip Janku, MD of MD Anderson discusses Next generation BRAF inhibitor cancer drug shows promise in early patient trial.In an…
Ruben Mesa, MD, Director Mays Cancer Center, UT Health San Antonio, MD Anderson Cancer Center discusses The Future Directions in…
Udai Banerji, MD, MBBS, DNB, Ph.D., FRCP from The Institute of Cancer Research and The Royal Marsden and Jon Pachter,…